Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,338 | 896 | 4,360 | 106 | 1,614 |
| Receivables | 111 | 95 | 24 | 6 | 5 |
| Inventories | 121 | 144 | 76 | 67 | 71 |
| TOTAL | $1,838 | $1,230 | $4,521 | $221 | $1,776 |
| Non-Current Assets | |||||
| PPE Net | 4 | 8 | 5 | 11 | 10 |
| Other Non-Current Assets | 194 | 342 | 338 | 262 | 197 |
| TOTAL | $198 | $350 | $343 | $273 | $207 |
| Total Assets | $2,036 | $1,580 | $4,865 | $494 | $1,983 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 409 | 640 | 797 | 565 | 297 |
| TOTAL | $409 | $640 | $797 | $565 | $297 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 279 | 477 | 434 | 2,428 | 1,895 |
| TOTAL | $279 | $477 | $434 | $2,428 | $1,895 |
| Total Liabilities | $688 | $1,117 | $1,231 | $2,993 | $2,192 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 1 | 1 |
| Common Shares | 5 | 4 | 4 | 2 | 2 |
| Retained earnings | -38,330 | -32,536 | -28,382 | -22,576 | -19,734 |
| TOTAL | $1,348 | $463 | $3,634 | $-2,499 | $-209 |
| Total Liabilities And Equity | $2,036 | $1,580 | $4,865 | $494 | $1,983 |